Kang YU
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tu B Cell Lymphoma, B Cell Leukemia, Myeloma | N/A | 2017-12-29 |